Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 3, 2009, Pages 263.e1-263.e6

  Kurtzman, James ^a   Chandiramani, Manju ^b   Briley, Annette ^c   Poston, Lucilla ^b   Das, Anita ^d   Shennan, Andrew ^b  

^a Pediatrix Medical Group   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d AxiStat Inc   (United States)

Author keywords

asymptomatic; cervicovaginal fetal fibronectin; preterm delivery; prior preterm birth; quantitative

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; SCREENING;

EID: 60849094792     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.01.018     Document Type: Article

References (14)

1. Callaghan W.M., MacDorman M.F., Rasmussen S.A., Qin C., and Lackritz E.M. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 118 (2006) 1566-1573
2. Gilbert W.M., Nesbitt T.S., and Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 102 (2003) 488-492
3. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births; NICHD MFMU network. Am J Public Health 88 (1998) 233-238
4. Iams J.D., Newman R.B., Thom E.A., et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 346 (2002) 250-255
5. Peaceman A.M., Andrews W.W., Thorp J.M., et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 177 (1997) 13-18
6. Goldenberg R.L., Mercer B.M., Meis P.J., Copper R.L., Das A., and McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth; NICHD maternal fetal medicine units network. Obstet Gynecol 87 (1996) 643-648
7. Shennan A., Crawshaw S., Briley A., et al. A randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG 113 (2006) 65-74
8. Kurtzman J.T. The delivery probability profile: a new tool to predict preterm delivery?. Contemp Obstet Gynecol 53 (2008) 1-5
9. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325 (1991) 669-674
10. Nageotte M.P., Casal D., and Senyei A.E. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 170 (1994) 20-25
11. Goepfert A.R., Goldenberg R.L., Mercer B., et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth: the National Institute of Child Health and Human Development maternal-fetal medicine units network. Am J Obstet Gynecol 183 (2000) 1480-1483
12. Lu G.C., Goldenberg R.L., Cliver S.P., Kreaden U.S., and Andrews W.W. Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women. Obstet Gynecol 97 (2001) 225-228
13. Honest H., Bachmann L.M., Gupta J.K., Kleijnen J., and Khan K.S. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 325 (2002) 301
14. Gomez R., Romero R., Medina L., et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 192 (2005) 350-359